947 related articles for article (PubMed ID: 31720080)
1. Development and validation of a m
Zhao X; Cui L
Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
[TBL] [Abstract][Full Text] [Related]
2. m
Hou J; Shan H; Zhang Y; Fan Y; Wu B
Am J Otolaryngol; 2020; 41(4):102547. PubMed ID: 32474328
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
4. Identification of a m
Chen J; Yu K; Zhong G; Shen W
Cancer Cell Int; 2020; 20():157. PubMed ID: 32419773
[TBL] [Abstract][Full Text] [Related]
5. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
[TBL] [Abstract][Full Text] [Related]
6. m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma.
Li F; Wang H; Huang H; Zhang L; Wang D; Wan Y
Front Genet; 2020; 11():994. PubMed ID: 33193582
[TBL] [Abstract][Full Text] [Related]
7. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.
Xu LC; Pan JX; Pan HD
Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S
Front Oncol; 2020; 10():718. PubMed ID: 32547941
[TBL] [Abstract][Full Text] [Related]
9. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X
Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079
[TBL] [Abstract][Full Text] [Related]
10. The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma.
Chen Y; Jiang X; Li X; Yan D; Liu J; Yang J; Yan S
Ann Transl Med; 2021 Aug; 9(16):1346. PubMed ID: 34532483
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma.
Pan J; Xu L; Pan H
Front Oncol; 2020; 10():1444. PubMed ID: 32974164
[No Abstract] [Full Text] [Related]
12. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
Zhao X; Cui L
J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
[TBL] [Abstract][Full Text] [Related]
13. Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer.
Wang S; Zou X; Chen Y; Cho WC; Zhou X
Front Genet; 2020; 11():580036. PubMed ID: 33584787
[No Abstract] [Full Text] [Related]
14. Diagnostic, progressive and prognostic performance of m
Zhuang Z; Chen L; Mao Y; Zheng Q; Li H; Huang Y; Hu Z; Jin Y
Int J Biol Sci; 2020; 16(11):1785-1797. PubMed ID: 32398949
[No Abstract] [Full Text] [Related]
15. Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma.
Paramasivam A; George R; Priyadharsini JV
Am J Cancer Res; 2021; 11(7):3688-3697. PubMed ID: 34354868
[TBL] [Abstract][Full Text] [Related]
16. Identification of pathology-specific regulators of m
Li N; Zhan X
EPMA J; 2020 Sep; 11(3):485-504. PubMed ID: 32849929
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma.
Wu X; Zhang X; Tao L; Dai X; Chen P
Biomed Res Int; 2020; 2020():2053902. PubMed ID: 32733931
[TBL] [Abstract][Full Text] [Related]
18. Construction and clinical evaluation of N6-methyladenosine risk signature of YTHDC2, IGF2BP2, and HNRNPC in head and neck squamous cell carcinoma.
Yue Q; Xu L; Zhang D
Hua Xi Kou Qiang Yi Xue Za Zhi; 2022 Dec; 40(6):704-709. PubMed ID: 36416324
[TBL] [Abstract][Full Text] [Related]
19. Gene Signature and Identification of Clinical Trait-Related m
Hou J; Wang Z; Li H; Zhang H; Luo L
Front Genet; 2020; 11():522. PubMed ID: 32754191
[TBL] [Abstract][Full Text] [Related]
20. m6A RNA methylation regulator-related signatures exhibit good prognosis prediction ability for head and neck squamous cell carcinoma.
Zhai Y; Zheng L
Sci Rep; 2022 Sep; 12(1):16358. PubMed ID: 36175504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
